Search clinical trials for: HeartMate II

Total 31371 results

North Eastern German Society of Gynaecological...

Completed

Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy

Ovarian Cancer

Germany
Halozyme Therapeutics

Completed

A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects

Healthy

United States
University of Wuerzburg

Unknown

VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT)

Multiple Myeloma

Austria, Germany, Italy
Austrian Breast & Colorectal Cancer Study Group

Completed

Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B

Colon Cancer Stage II

Austria
Austrian Breast & Colorectal Cancer Study Group

Completed

Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C

Colon Cancer Stage III

Austria
University of Copenhagen
Metabolife

Completed

B181 Metobes-III: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)

Obesity

Denmark
Rambam Health Care Campus

Unknown

Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs

NIDDM

Israel
OSI Pharmaceuticals

Completed

A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer

Locally Advanced or Metastatic Adenoca of the Biliary Tract

United States, Belgium, Germany, Poland, Romania, Switzerland
Tel-Aviv Sourasky Medical Center

Unknown

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer

Colon Neoplasm
OSI Pharmaceuticals

Completed

Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer

Gastric Adenocarcinoma | Gastroesophageal Adenocarcinoma

United States, United Kingdom, Belgium
Charite University, Berlin, Germany
Pfizer; Aventis Pharmaceuticals

Unknown

A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

Small Cell Lung Cancer

Germany
Genta Incorporated

Completed

Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma | Refractory Lymphoma | Relapsed Lymphoma | Low-Grade Lymphoma | Intermediate-Grade Lymphoma

United States
Chiron Corporation

Terminated

Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL)

Non-Hodgkin Lymphoma

United States
Hokkaido Gastrointestinal Cancer Study Group

Suspended

Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer

Gastric Cancer

Japan
IRCCS San Raffaele

Completed

Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease

Coronary Artery Disease | Type II Diabetes Mellitus
West Japan Thoracic Oncology Group

Unknown

Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer

Lung Cancer

Japan
West Japan Thoracic Oncology Group

Completed

Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Lung Cancer
The University of New South Wales

Completed

Escitalopram as a Mood Stabilizer for Bipolar II Disorder

Bipolar Disorders

Australia
Daiichi Sankyo, Inc.

Completed

A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

Hypertension | Metabolic Syndrome | Insulin Resistance

United States
Rennes University Hospital
Wyeth is now a wholly owned subsidiary of Pfizer; Bayer; Farmades, Italy

Terminated

Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis

France, Italy
National Health Research Institutes, Taiwan
Mackay Memorial Hospital; China Medical University Hospital; Chang Gung Memorial... and other collaborators

Unknown

Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer

Adenocarcinoma | Colonic Diseases

Taiwan
J. Uriach and Company

Completed

Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy Volunteers

Human Experimentation (Human Volunteers)

Spain
Johann Wolfgang Goethe University Hospital
Gilead Sciences

Unknown

A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients

HIV

Germany
Chinese University of Hong Kong

Unknown

Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial

Cancer of Stomach

China
Carlos III Health Institute
Spanish Society of Pneumology and Thoracic Surgery

Unknown

Home Treatment of Pulmonary Embolism

Pulmonary Embolism

Spain
National Health Research Institutes, Taiwan

Completed

A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers

Non-Hodgkin's Lymphoma

Taiwan
National Health Research Institutes, Taiwan

Completed

Phase III Study OF the Gastric Surgery on Advanced Stage Gastric Cancer

Gastric Cancer
Poitiers University Hospital
Novartis; Ministry of Health, France

Terminated

Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients

Chronic Myeloid Leukemia

France
Connolly, Stuart, M.D.
Bristol-Myers Squibb; Sanofi

Unknown

Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers

Hypertension | Atrial Fibrillation

Canada
National Taiwan University Hospital
National Health Research Institutes, Taiwan

Completed

A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma
Hannover Medical School
University Hospital, Ghent; Johann Wolfgang Goethe University Hospital; University... and other collaborators

Unknown

Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T

De Novo Akute Myeloid Leukemia (AML) | Secondary Acute Myeloid Leukemia (AML) | Refractory Anemia With Excess of Blasts in Transformation

Germany
Chinese University of Hong Kong

Unknown

Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial

Cancer of Stomach

China
Boston University

Completed

Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia

Beta-Thalassemia

United States, United Kingdom
Millennium Pharmaceuticals, Inc.

Completed

PROTECT-TIMI 30 Trial

Unstable Angina
Zeneus Pharma

Unknown

Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer

Metastatic Breast Cancer

Italy
Celgene Corporation
Prologue Research International

Terminated

A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

Pancreatic Cancer

United States
ARCAGY/ GINECO GROUP

Completed

Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV

Ovarian Cancer

France
Jikei University School of Medicine

Unknown

A Morbidity-Mortality and Remodeling Study With Valsartan

Hypertension | Ischemic Heart Disease | Congestive Heart Failure

Japan
Zeneus Pharma

Unknown

Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.

Aggressive Non-Hodgkin's Lymphoma in the Elderly.

France, Germany, Spain, United Kingdom, Italy
University Hospital, Rouen

Completed

Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial

Esophageal Neoplasms

France
Cell Genesys

Completed

A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer | Nonresectable Pancreatic Cancer

United States
Johann Wolfgang Goethe University Hospital

Unknown

Efficacy of G-CSF-Priming in Elderly AML Patients

Acute Myeloid Leukemia

Germany
Integrated Community Oncology Network
Sanofi

Unknown

Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.

Previously Treated Metastatic Non-Small Cell Lung Cancer

United States
Odense University Hospital
University of Southern Denmark; Lundbeck Foundation; Else Poulsen Mindelegat

Unknown

Prevention of Decompensation in Liver Cirrhosis

Ascites | Alcoholic Liver Cirrhosis

Denmark
University of Manitoba
Janssen-Ortho Inc., Canada; PriCara, Unit of Ortho-McNeil, Inc.; Ortho-McNeil...

Terminated

Safety and Efficacy Study of the Treatment of Kidney Infections With Short Course Levofloxacin

Acute Uncomplicated Pyelonephritis

Canada
University Medicine Greifswald

Completed

Studying the Analgesic Mechanism of the "Cough-Trick"

Pain | Acute Pain | Venipuncture
Charles University, Czech Republic
Ministry of Health, Czech Republic; Czech Ministry of Education

Unknown

TDI Preejection Velocities and Myocardial Viability

Coronary Artery Disease

Czech Republic
Kyoto University, Graduate School of Medicine

Unknown

Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure

Liver Failure, Acute

Japan
Institut de Recherche pour le Developpement
World Health Organization; European Commission

Unknown

A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis

Tuberculosis

Kenya, Benin, Guinea, Senegal, South Africa
Department of Veterans Affairs, New Jersey
Pfizer

Unknown

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

Prostate Cancer

United States

Search clinical trials for: HeartMate II

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations